Patents by Inventor Joseph Garlich

Joseph Garlich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070203098
    Abstract: The therapeutic use of inhibitors of PTEN activity in the treatment of PTEN-mediated diseases, conditions, and injuries is disclosed.
    Type: Application
    Filed: April 6, 2005
    Publication date: August 30, 2007
    Applicant: Semafore Pharmaceuticals, Inc.
    Inventors: Joseph Garlich, Donald Durden, Taxiarchis Georgiadis, Jingdong Su, Xiaodong Peng, Tim Smith
  • Publication number: 20070104645
    Abstract: This invention relates to novel complexes that can be used to target tumor cells. The complexes include a ligand that can bind metal ions including radioactive lanthanide ions. The complexes can mimic ???3 integrin receptor antagonists and deliver the complexed radioactive metals to the tumor cells.
    Type: Application
    Filed: September 30, 2004
    Publication date: May 10, 2007
    Inventors: Joseph Garlich, Robert Suhr, Mary Patterson
  • Publication number: 20050203173
    Abstract: The invention provides novel prodrugs of inhibitors of PI-3 kinase. The novel compounds are LY294002 and analogs thereof comprising a reversibly quaternized amine.
    Type: Application
    Filed: April 20, 2005
    Publication date: September 15, 2005
    Inventors: Joseph Garlich, Donald Durden, Mary Patterson, Jingdong Su, Robert Suhr